Literature DB >> 16566863

Capsaicin treatment of idiopathic rhinitis: the new panacea?

Jeroen B van Rijswijk, Roy Gerth van Wijk.   

Abstract

The management of patients with perennial nonallergic or idiopathic rhinitis is difficult. Diagnosis and treatment are hampered by several factors. First, the diagnosis is made by exclusion of other nasal diseases. As a consequence, idiopathic rhinitis is not defined according to clear-cut criteria. A commonly accepted phenotype of idiopathic rhinitis does not exist. Second, the pathophysiology of idiopathic rhinitis is not yet fully elucidated. In contrast with allergic rhinitis, inflammation does not appear to play an important role in idiopathic rhinitis. Recent studies indicate a neural dysregulation of the nasal mucosa. Additionally, the available therapeutic arsenal comprising both pharmacotherapy and surgery is at best partially efficacious in these patients. The efficacy of repeated capsaicin application has been established in several randomized controlled trials. This treatment modality may be the first step to more specific and better treatment options for patients with idiopathic rhinitis that is unresponsive to standard treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16566863     DOI: 10.1007/s11882-006-0051-2

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  48 in total

1.  The vasomotor activities of the nasal mucous membrane.

Authors:  K G MALCOMSON
Journal:  J Laryngol Otol       Date:  1959-02       Impact factor: 1.469

Review 2.  Basic mechanisms in autonomic nervous responses in specific and nonspecific nasal hyperreactivity.

Authors:  A Anggård
Journal:  Acta Otolaryngol       Date:  1993-05       Impact factor: 1.494

3.  Peptide immunoreactivity and ultrastructure of rat urinary bladder nerve fibers after topical desensitization by capsaicin or resiniferatoxin.

Authors:  A Avelino; F Cruz
Journal:  Auton Neurosci       Date:  2000-12-28       Impact factor: 3.145

4.  Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin.

Authors:  N Jancsó; A Jancsó-Gábor; J Szolcsányi
Journal:  Br J Pharmacol Chemother       Date:  1967-09

5.  Neuropeptide innervation and neuroendocrine cells in allergic rhinitis and chronic hypertrophic rhinitis.

Authors:  S Y Fang; C L Shen
Journal:  Clin Exp Allergy       Date:  1998-02       Impact factor: 5.018

6.  The nasal response to isometric exercise in non-eosinophilic intrinsic rhinitis.

Authors:  A D Wilde; J A Cook; A S Jones
Journal:  Clin Otolaryngol Allied Sci       Date:  1996-02

7.  Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study.

Authors:  H M Blom; J B Van Rijswijk; I M Garrelds; P G Mulder; T Timmermans; R Gerth van Wijk
Journal:  Clin Exp Allergy       Date:  1997-07       Impact factor: 5.018

8.  Ultracytochemical localization of the NADPH-d activity in the human nasal respiratory mucosa in vasomotor rhinitis.

Authors:  R Ruffoli; B Fattori; M A Giambelluca; P Soldani; F Giannessi
Journal:  Laryngoscope       Date:  2000-08       Impact factor: 3.325

9.  Characterization and quantification of cellular infiltrates in nasal mucosa of patients with grass pollen allergy, non-allergic patients with nasal polyps and controls.

Authors:  W J Fokkens; A F Holm; E Rijntjes; P G Mulder; T M Vroom
Journal:  Int Arch Allergy Appl Immunol       Date:  1990

10.  Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomized application regimen study.

Authors:  J B Van Rijswijk; E L Boeke; J M Keizer; P G H Mulder; H M Blom; W J Fokkens
Journal:  Allergy       Date:  2003-08       Impact factor: 13.146

View more
  1 in total

1.  BSACI guidelines for the management of allergic and non-allergic rhinitis.

Authors:  G K Scadding; S R Durham; R Mirakian; N S Jones; S C Leech; S Farooque; D Ryan; S M Walker; A T Clark; T A Dixon; S R A Jolles; N Siddique; P Cullinan; P H Howarth; S M Nasser
Journal:  Clin Exp Allergy       Date:  2008-01       Impact factor: 5.018

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.